Actym Therapeutics Appoints Thomas Smart as CEO
BERKELEY, CA — April 24, 2024 Actym Therapeutics, pioneering a new drug modality to treat solid tumors, announced today the appointment of Thomas Smart as Chief Executive Officer. With 25 years of experience in senior management and executive roles as well as Board of Directors positions across the biopharmaceutical industry, Mr. Smart brings a significant […]
Article Date
April 24, 2024
This article is featured on another website.
Go to article
August 26, 2026
Asia’s Shifting Regulatory Map: What Sponsors Need to Know Before Choosing a Trial Location
Part 3 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
August 26, 2026
Asia’s Shifting Regulatory Map: What Sponsors Need to Know Before Choosing a Trial Location
Part 3 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…
July 10, 2026
Sarcoma Clinical Trials – Cell Therapy’s Solid-Tumor Breakthrough, and What It Means for a Rare Cancer
A Turning Point for Cell Therapy in Solid Tumors, and for Sarcoma For most of…
July 10, 2026
Sarcoma Clinical Trials – Cell Therapy’s Solid-Tumor Breakthrough, and What It Means for a Rare Cancer
A Turning Point for Cell Therapy in Solid Tumors, and for Sarcoma For most of…